Abstract
The principal peripheral pharmacokinetic parameters of the levodopa/carbidopa association were investigated in 11 healthy volunteers and in 16 patients at various stages of Parkinson disease, with and without the on-off phenomenon. After oral administration of a standard dose of drug (levodopa 250 mg + carbidopa 25 mg) the peak plasma concentrations, peak onset time and area under the curve/time proved to be similar across the groups. There was no difference in peripheral pharmacokinetics of the association between parkinsonian patients with swings in response and those without.
Sommario
I principali parametri farmacocinetici periferici della associazione levodopa/carbidopa sono stati studiati in 11 volontari sani ed in 16 pazienti affetti da morbo di Parkinson in differenti stadi di malattia, con e senza fluttuazioni delle performances motorie.
Dopo somministrazione per via orale di una dose standard del farmaco (levodopa 250 mg., carbidopa 25 mg.), i valori della concentrazione plasmatica massima, del tempo di comparsa del picco e dell'area sotto la curva concentrazione/tempo sono risultati simili in tutti i gruppi esaminati.
La farmacocinetica periferica dell'associazione levodopa/carbidopa non è risultata essere differente nei parkinsoniani che presentavano delle fluttuazioni delle performances motorie in confronto ai pazienti con stabile risposta clinica alla terapia.
Similar content being viewed by others
References
Quinn N., Parkes J.D., Marsden C.D.:Control of on/off fenomenon by continuous intravenous infusion of levodopa. Neurology, 34:1131–1136, 1984.
Lewitt P.A., Chase T.N.:“On-Off” effects: the new challenge in parkinsonism. Trends Nuerosci, 6:1–4, 1983.
Shoulson I., George A., Glaubiger A., Chase T.N.:On-Off response. Neurology, 25:1144–1148, 1975.
Hardie R.J., Lees A.J., Stern G.M.:On-Off fluctuations in Parkinson's disease. Brain, 107:487–506, 1984.
Nutt J.G., Fellman J.H.:Pharmacokinetics of levodopa. Clin Neuropharmacol, 7:35–49, 1984.
Nissinen E., Taskinen J.:Simultaneous determination of levodopa and 3, 4-dihydroxyphenylacetic acid using high-performance liquid chromatography with electrochemical detection. J. Chromatogr, 231: 459, 462, 1982.
Abrams W.B., Coutinho C.B., Leon A., Spiegel H.A.:Absorption and metabolism of levodopa. JAMA, 218:1912–1914, 1971.
Evans M.A., Triggs E.J., Broe G.A., Saines N.:Systemic availability of orally administered L-DOPA in the elderly parkinsonian patients. Eur. J. Clin. Pharmacol, 17:215–221, 1980.
Awapara J., Saine S.:Fluctuations in DOPA decarboxylase activity with age. J. Neurochem, 24: 817–818, 1975.
Wade D.N., Mearrick P.T., Birkett D.J., Morris J.:Variability of L-DOPA absorption in man. Aust. Nz. J. Med. 4:138–143, 1974.
Tolosa E.S., Martin W.E., Cohen H.P., Jacobson R.L.:Pattern of clinical response and plasma DOPA levels in Parkinson's disease. Neurology, 25: 177–183, 1975.
Papavasiliou P.S., McDowell F.H., Wang Y.Y., Rosal V., Miller S.T.:Plasma DOPA and growth hormone in parkinsonism: oscillations in symptoms. Neurology, 29:194–200, 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rainero, I., Gilli, M., De Gennaro, T. et al. Peripheral pharmacokinetic parameters of levodopa/carbidopa and the on-off phenomenon in parkinsonian patients. Ital J Neuro Sci 9, 255–259 (1988). https://doi.org/10.1007/BF02334049
Issue Date:
DOI: https://doi.org/10.1007/BF02334049